BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38324963)

  • 1. Clear-cell papillary renal cell tumour: New insights into clinicopathological features and molecular landscape after renaming by 5th WHO classification.
    Zhang W; Zhang L; Wen Z; Liang J; Wang Y; Wang Z; Yin Z; Fan L
    Pathol Res Pract; 2024 Mar; 255():155167. PubMed ID: 38324963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management.
    Weng S; DiNatale RG; Silagy A; Mano R; Attalla K; Kashani M; Weiss K; Benfante NE; Winer AG; Coleman JA; Reuter VE; Russo P; Reznik E; Tickoo SK; Hakimi AA
    Eur Urol; 2021 Apr; 79(4):468-477. PubMed ID: 33046271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Sarcomatoid Renal Cell Carcinoma with Clear Cell Papillary-Like Primary Tumor and Lymph Node Metastasis: A Diagnostic Conundrum.
    Demko N; Glennon KI; Arseneault M; Lach K; Nishimura T; Tanguay S; Riazalhosseini Y; Brimo F
    Int J Surg Pathol; 2023 Aug; 31(5):890-895. PubMed ID: 36562104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological and prognostic characteristics of clear cell papillary renal cell carcinoma].
    Xu YW; Zhou JC; Xie HB; Yang WP; Li L; Zhang KN; Ma KF; Gong YQ; Zhang Z; Cai L; Gong K
    Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(46):3784-3788. PubMed ID: 34895417
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical features and survival analysis of clear cell papillary renal cell carcinoma: A 10-year retrospective study from two institutions.
    Wang Y; Ding Y; Wang J; Gu M; Wang Z; Qin C; Han C; Li H; Liu X; Wu P; Li G
    Oncol Lett; 2018 Jul; 16(1):1010-1022. PubMed ID: 29963177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncocytic papillary renal cell carcinoma: A clinicopathological and genetic analysis and indolent clinical course in 14 cases.
    Han G; Yu W; Chu J; Liu Y; Jiang Y; Li Y; Zhang W
    Pathol Res Pract; 2017 Jan; 213(1):1-6. PubMed ID: 27931799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
    Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
    Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary renal neoplasm with reverse polarity: A clinicopathological and molecular genetic characterization of 16 cases with expanding the morphologic spectrum and further support for a novel entity.
    Shen M; Yin X; Bai Y; Zhang H; Ru G; He X; Teng X; Chen G; Zhao M
    Front Oncol; 2022; 12():930296. PubMed ID: 35936734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.
    Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK
    Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic squamoid alveolar papillary renal cell carcinoma: A unique papillary renal cell carcinoma with distinctive morphology, immunophenotype and molecular genetic features.
    Li Y; Wu X; Yang J; Jiang Y; Li Y; Zhang W; Yu W
    Pathol Res Pract; 2022 Nov; 239():154120. PubMed ID: 36201928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological and molecular genetic characteristics of ELOC mutated renal cell carcinoma].
    Wen Z; Zhang WH; Liang JY; Chai J; Wang YM; Xu WN; Wang Z; Fan LN
    Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1204-1209. PubMed ID: 38058035
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytomorphologic analysis of clear cell papillary renal cell carcinoma: Distinguishing diagnostic features.
    Griffin BB; Lin X
    Cancer Cytopathol; 2021 Mar; 129(3):192-203. PubMed ID: 33036062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic features and differential diagnosis of multilocular cystic renal cell carcinoma].
    Zhang W; Li Y; Lu Q; Zhuang J; Wang Q; Zhao H; Yu W; Kang E; Feng Z
    Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):723-7. PubMed ID: 25582248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clear cell papillary renal cell carcinoma: a distinct low-grade renal tumour].
    Yang X; Miao N; Gan H; Wang L; Wang C
    Zhonghua Bing Li Xue Za Zhi; 2015 Jun; 44(6):372-6. PubMed ID: 26704829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
    Halefoglu AM; Ozagari AA
    Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutations in renal cell carcinomas from Chinese patients revealed by whole exome sequencing.
    Wang J; Xi Z; Xi J; Zhang H; Li J; Xia Y; Yi Y
    Cancer Cell Int; 2018; 18():159. PubMed ID: 30349421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy.
    Tian X; Xu WH; Wu JL; Gan HL; Wang HK; Gu WJ; Qu YY; Zhang HL; Ye DW
    Pathol Oncol Res; 2021; 27():1609809. PubMed ID: 34512202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSC/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: a comprehensive study of 12 cases.
    Tjota MY; Sharma A; Wanjari P; Fitzpatrick C; Segal J; Antic T
    Hum Pathol; 2023 Apr; 134():124-133. PubMed ID: 36592877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathological features and prognostic analysis of papillary renal cell carcinoma].
    Bo ES; Hong P; Zhang Y; Deng SH; Ge LY; Lu M; Li N; Ma LL; Zhang SD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):615-620. PubMed ID: 35950382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.